Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",blood insulin amount,,RS:0000916,WKY/NHsd,female,119 days,10,,CMO:0000342,plasma insulin level,,,,20,mU/l,2.5,7.9057,MMO:0000164,intraperitoneal glucose tolerance test,,0,,post glucose injection,60,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,11614,fasting (for 16 hours),glucose solution (2 g/kg) , 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",blood insulin amount,,RS:0000916,WKY/NHsd,male,119 days,10,,CMO:0000342,plasma insulin level,,,,64.1,mU/l,9.7,30.6741,MMO:0000164,intraperitoneal glucose tolerance test,,0,,post glucose injection,60,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,11612,fasting (for 16 hours),glucose solution (2 g/kg) , 252,"Baum AE, et al., Endocrinology 2004 Oct 28;.",blood thyroid-stimulating hormone amount,,RS:0000916,WKY/NHsd,female,0 days to 70 days,15,,CMO:0001248,serum thyroid stimulating hormone level,,serum tsh,,3,ng/ml,0.0542,0.21,MMO:0000073,radioimmunoassay,,0.0,,,,,naive control condition,67898,naive control condition,, 252,"Baum AE, et al., Endocrinology 2004 Oct 28;.",blood thyroid-stimulating hormone amount,,RS:0000916,WKY/NHsd,male,0 days to 70 days,16,,CMO:0001248,serum thyroid stimulating hormone level,,serum tsh,,5.28,ng/ml,0.29,1.16,MMO:0000073,radioimmunoassay,,0.0,,,,,naive control condition,67897,naive control condition,, 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood creatinine amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0000537,plasma creatinine level,,,,0.31787282,mg/dl,0.0113,0.032,MMO:0000306,plasma creatinine analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99174,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),sunitinib (7 mg/kg/d) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood creatinine amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0000537,plasma creatinine level,,,,0.30090452,mg/dl,0.0079,0.021,MMO:0000306,plasma creatinine analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99173,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),vehicle control condition (0.5 ml) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood creatinine amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0000537,plasma creatinine level,,,,0.35180942,mg/dl,0.017,0.048,MMO:0000306,plasma creatinine analysis,,0.0,,,,,standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99172,standard rat chow (for 8 days),sunitinib (7 mg/kg/d) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood creatinine amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0000537,plasma creatinine level,,,,0.30882306,mg/dl,0.0102,0.0269,MMO:0000306,plasma creatinine analysis,,0.0,,,,,standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99171,standard rat chow (for 8 days),vehicle control condition (0.5 ml) (for 8 days), 141,"Lan H, et al., Genetics 2001 Jan;157(1):331-9",mammary gland integrity trait,,RS:0000916,WKY/NHsd,female,174 days to 169 days,17,,CMO:0000343,mammary tumor number,,3X3 mm diameter or larger,,0,,,,MMO:0000344,necropsy,,,,,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11741,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",, 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",arterial blood pressure trait,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0000009,mean arterial blood pressure,,,,124,mmHg,4.0,11.3137,MMO:0000577,intra-aortic radiotelemetry,,0.0,,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99190,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),sunitinib (7 mg/kg/d) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",arterial blood pressure trait,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0000009,mean arterial blood pressure,,,,116,mmHg,1.0,2.6458,MMO:0000577,intra-aortic radiotelemetry,,0.0,,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99189,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),vehicle control condition (0.5 ml) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",arterial blood pressure trait,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0000009,mean arterial blood pressure,,,,128,mmHg,3.0,8.4853,MMO:0000577,intra-aortic radiotelemetry,,0.0,,,,,standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99188,standard rat chow (for 8 days),sunitinib (7 mg/kg/d) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",arterial blood pressure trait,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0000009,mean arterial blood pressure,,,,101,mmHg,0.9,2.3812,MMO:0000577,intra-aortic radiotelemetry,,0.0,,,,,standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99187,standard rat chow (for 8 days),vehicle control condition (0.5 ml) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood chloride amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0000059,plasma chloride level,,,,104.8,mmol/l,1.8,4.7624,MMO:0000037,automated blood electrolyte analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99169,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),vehicle control condition (0.5 ml) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood chloride amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0000059,plasma chloride level,,,,109.1,mmol/l,1.0,2.8284,MMO:0000037,automated blood electrolyte analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99170,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),sunitinib (7 mg/kg/d) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood chloride amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0000059,plasma chloride level,,,,100.5,mmol/l,0.5,1.4142,MMO:0000037,automated blood electrolyte analysis,,0.0,,,,,standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99168,standard rat chow (for 8 days),sunitinib (7 mg/kg/d) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood chloride amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0000059,plasma chloride level,,,,98.2,mmol/l,1.1,2.9103,MMO:0000037,automated blood electrolyte analysis,,0.0,,,,,standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99167,standard rat chow (for 8 days),vehicle control condition (0.5 ml) (for 8 days), 105,"Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8",adrenal gland mass,,RS:0000916,WKY/NHsd,female,112 days,20,,CMO:0000164,both adrenal glands wet weight,,,,65.8,mg,1.8,8.0498,MMO:0000005,post excision weight measurement,,,,,,,naive control condition,11602,naive control condition,, 105,"Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8",adrenal gland mass,,RS:0000916,WKY/NHsd,male,112 days,24,,CMO:0000164,both adrenal glands wet weight,,,,43,mg,1.2,5.8788,MMO:0000005,post excision weight measurement,,,,,,,naive control condition,11600,naive control condition,, 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",blood glucose amount,,RS:0000916,WKY/NHsd,female,119 days,10,,CMO:0000042,plasma glucose level,,,,84.3,mg/dl,6.9,21.8197,MMO:0000315,plasma glucose analysis,,0,,,,,fasting (for 16 hours) then glucose solution (2 g/kg) ,13184,fasting (for 16 hours),glucose solution (2 g/kg) , 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",blood glucose amount,,RS:0000916,WKY/NHsd,female,119 days,10,,CMO:0000042,plasma glucose level,,,,163.7,mg/dl,7.2,22.7684,MMO:0000164,intraperitoneal glucose tolerance test,,0,,post glucose injection,60,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,13183,fasting (for 16 hours),glucose solution (2 g/kg) , 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",blood glucose amount,,RS:0000916,WKY/NHsd,female,105 days,10,,CMO:0000042,plasma glucose level,,,,151.6,mg/dl,4.7,14.8627,MMO:0000315,plasma glucose analysis,,0,,,,,physical restraint in tube type rodent restrainer (for 0.5 hours),13182,physical restraint in tube type rodent restrainer (for 0.5 hours),, 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",blood glucose amount,,RS:0000916,WKY/NHsd,male,105 days,10,,CMO:0000042,plasma glucose level,,,,153.5,mg/dl,6.3,19.9223,MMO:0000315,plasma glucose analysis,,0,,,,,physical restraint in tube type rodent restrainer (for 0.5 hours),13175,physical restraint in tube type rodent restrainer (for 0.5 hours),, 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",blood glucose amount,,RS:0000916,WKY/NHsd,male,119 days,10,,CMO:0000042,plasma glucose level,,,,98.1,mg/dl,2.5,7.9057,MMO:0000315,plasma glucose analysis,,0,,,,,fasting (for 16 hours) then glucose solution (2 g/kg) ,13174,fasting (for 16 hours),glucose solution (2 g/kg) , 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",blood glucose amount,,RS:0000916,WKY/NHsd,male,119 days,10,,CMO:0000042,plasma glucose level,,,,173.8,mg/dl,5.5,17.3925,MMO:0000164,intraperitoneal glucose tolerance test,,0,,post glucose injection,60,min,fasting (for 16 hours) then glucose solution (2 g/kg) ,13173,fasting (for 16 hours),glucose solution (2 g/kg) , 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood sodium amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0000060,plasma sodium level,,,,139.4,mmol/l,1.7,4.8083,MMO:0000037,automated blood electrolyte analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99162,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),sunitinib (7 mg/kg/d) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood sodium amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0000060,plasma sodium level,,,,141.4,mmol/l,2.1,5.5561,MMO:0000037,automated blood electrolyte analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99161,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),vehicle control condition (0.5 ml) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood sodium amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0000060,plasma sodium level,,,,137.8,mmol/l,2.3,6.5054,MMO:0000037,automated blood electrolyte analysis,,0.0,,,,,standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99160,standard rat chow (for 8 days),sunitinib (7 mg/kg/d) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood sodium amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0000060,plasma sodium level,,,,143.7,mmol/l,4.4,11.6413,MMO:0000037,automated blood electrolyte analysis,,0.0,,,,,standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99159,standard rat chow (for 8 days),vehicle control condition (0.5 ml) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",glomerular filtration trait,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0000765,creatinine clearance,,,,3.5,ml/min,0.2,0.5657,MMO:0000275,urine creatinine analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99182,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),sunitinib (7 mg/kg/d) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",glomerular filtration trait,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0000765,creatinine clearance,,,,3.5,ml/min,0.3,0.7937,MMO:0000275,urine creatinine analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99181,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),vehicle control condition (0.5 ml) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",glomerular filtration trait,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0000765,creatinine clearance,,,,3.1,ml/min,0.5,1.4142,MMO:0000275,urine creatinine analysis,,0.0,,,,,standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99180,standard rat chow (for 8 days),sunitinib (7 mg/kg/d) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",glomerular filtration trait,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0000765,creatinine clearance,,,,3.1,ml/min,0.5,1.3229,MMO:0000275,urine creatinine analysis,,0.0,,,,,standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99179,standard rat chow (for 8 days),vehicle control condition (0.5 ml) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood potassium amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0000061,plasma potassium level,,,,4.4,mmol/l,0.4,1.1314,MMO:0000037,automated blood electrolyte analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99166,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),sunitinib (7 mg/kg/d) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood potassium amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0000061,plasma potassium level,,,,4.2,mmol/l,0.3,0.7937,MMO:0000037,automated blood electrolyte analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99165,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),vehicle control condition (0.5 ml) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood potassium amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0000061,plasma potassium level,,,,4.2,mmol/l,0.3,0.8485,MMO:0000037,automated blood electrolyte analysis,,0.0,,,,,standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99164,standard rat chow (for 8 days),sunitinib (7 mg/kg/d) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood potassium amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0000061,plasma potassium level,,,,3.9,mmol/l,0.2,0.5292,MMO:0000037,automated blood electrolyte analysis,,0.0,,,,,standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99163,standard rat chow (for 8 days),vehicle control condition (0.5 ml) (for 8 days), 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",body mass,,RS:0000916,WKY/NHsd,female,119 days,10,,CMO:0000012,body weight,,,,230,g,3.2,10.1193,MMO:0000016,body weighing method,,0,,,,,fasting (for 16 hours),11610,fasting (for 16 hours),, 107,"Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22",body mass,,RS:0000916,WKY/NHsd,male,119 days,10,,CMO:0000012,body weight,,,,352,g,4.5,14.2302,MMO:0000016,body weighing method,,0,,,,,fasting (for 16 hours),11608,fasting (for 16 hours),, 972,"Baum AE, et al., Behav Brain Res. 2006 Feb 17;.",locomotor behavior trait,,RS:0000916,WKY/NHsd,female,88 days to 77 days,22,,CMO:0000960,number of entries into a discrete space in an experimental apparatus,,in 10min; unprompted,,6.2,,1.4284,6.7,MMO:0000258,open field apparatus method,,600.0,,,,,naive control condition,75706,naive control condition,, 972,"Baum AE, et al., Behav Brain Res. 2006 Feb 17;.",locomotor behavior trait,,RS:0000916,WKY/NHsd,male,88 days to 77 days,28,,CMO:0000960,number of entries into a discrete space in an experimental apparatus,,in 10min; unprompted,,4,,0.8693,4.6,MMO:0000258,open field apparatus method,,600.0,,,,,naive control condition,75704,naive control condition,, 105,"Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8",blood corticosterone amount,,RS:0000916,WKY/NHsd,female,105 days,20,,CMO:0001173,plasma corticosterone level,,,,584.5,ng/ml,33.5,149.8166,MMO:0000073,radioimmunoassay,,0,,,,,physical restraint (for 0.2 hours),13128,physical restraint (for 0.2 hours),, 105,"Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8",blood corticosterone amount,,RS:0000916,WKY/NHsd,male,105 days,24,,CMO:0001173,plasma corticosterone level,,ng/ml,,287.5,ng/ml,21.0,102.8786,MMO:0000073,radioimmunoassay,,0,,,,,physical restraint (for 0.2 hours),13124,physical restraint (for 0.2 hours),, 105,"Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8",blood corticosterone amount,,RS:0000916,WKY/NHsd,female,105 days,20,,CMO:0001173,plasma corticosterone level,,,,113,ng/ml,18.9,84.5234,MMO:0000073,radioimmunoassay,,,,,,,naive control condition,13121,naive control condition,, 105,"Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8",blood corticosterone amount,,RS:0000916,WKY/NHsd,male,105 days,24,,CMO:0001173,plasma corticosterone level,,ng/ml,,31.7,ng/ml,4.2,20.5757,MMO:0000073,radioimmunoassay,,,,,,,naive control condition,13118,naive control condition,, 972,"Baum AE, et al., Behav Brain Res. 2006 Feb 17;.",grooming behavior trait,,RS:0000916,WKY/NHsd,male,88 days to 77 days,26,,CMO:0001749,duration of grooming in an experimental apparatus,,in 10min,,82.4,s,12.3357,62.9,MMO:0000559,defensive burying test,,600.0,defensive burying apparatus,,,,naive control condition,75702,naive control condition,, 972,"Baum AE, et al., Behav Brain Res. 2006 Feb 17;.",grooming behavior trait,,RS:0000916,WKY/NHsd,female,88 days to 77 days,16,,CMO:0001749,duration of grooming in an experimental apparatus,,in 10min,,97.9,s,17.75,71.0,MMO:0000559,defensive burying test,,600.0,defensive burying apparatus,,,,naive control condition,75700,naive control condition,, 972,"Baum AE, et al., Behav Brain Res. 2006 Feb 17;.",grooming behavior trait,,RS:0000916,WKY/NHsd,female,88 days to 77 days,22,,CMO:0001749,duration of grooming in an experimental apparatus,,in 10min,,42.5,s,6.1189,28.7,MMO:0000258,open field apparatus method,,600.0,,,,,naive control condition,75696,naive control condition,, 972,"Baum AE, et al., Behav Brain Res. 2006 Feb 17;.",grooming behavior trait,,RS:0000916,WKY/NHsd,male,88 days to 77 days,28,,CMO:0001749,duration of grooming in an experimental apparatus,,in 10min,,35.3,s,7.4837,39.6,MMO:0000258,open field apparatus method,,600.0,,,,,naive control condition,68654,naive control condition,, 972,"Baum AE, et al., Behav Brain Res. 2006 Feb 17;.",body movement coordination trait,,RS:0000916,WKY/NHsd,female,88 days to 77 days,22,,CMO:0001752,number of rearing movements in an experimental apparatus,,in 10min,,20.5,,2.2599,10.6,MMO:0000258,open field apparatus method,,600.0,,,,,naive control condition,75692,naive control condition,, 972,"Baum AE, et al., Behav Brain Res. 2006 Feb 17;.",body movement coordination trait,,RS:0000916,WKY/NHsd,male,88 days to 77 days,28,,CMO:0001752,number of rearing movements in an experimental apparatus,,in 10min,,9.6,,1.3796,7.3,MMO:0000258,open field apparatus method,,600.0,,,,,naive control condition,75698,naive control condition,, 972,"Baum AE, et al., Behav Brain Res. 2006 Feb 17;.",body movement coordination trait,,RS:0000916,WKY/NHsd,male,88 days to 77 days,26,,CMO:0001752,number of rearing movements in an experimental apparatus,,in 10min,,17.8,,1.4513,7.4,MMO:0000559,defensive burying test,,600.0,defensive burying apparatus,,,,naive control condition,75694,naive control condition,, 972,"Baum AE, et al., Behav Brain Res. 2006 Feb 17;.",body movement coordination trait,,RS:0000916,WKY/NHsd,female,88 days to 77 days,16,,CMO:0001752,number of rearing movements in an experimental apparatus,,in 10min,,33.8,,2.65,10.6,MMO:0000559,defensive burying test,,600.0,defensive burying apparatus,,,,naive control condition,68652,naive control condition,, 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin potassium amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0002773,skin potassium level to skin water level ratio,,skin k/h2o,,69,mmol/l,2.5,7.0711,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99158,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),sunitinib (7 mg/kg/d) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin potassium amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0002773,skin potassium level to skin water level ratio,,skin k/h2o,,71,mmol/l,3.0,7.9373,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99157,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),vehicle control condition (0.5 ml) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin potassium amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0002773,skin potassium level to skin water level ratio,,skin k/h2o,,75,mmol/l,1.8,5.0912,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99156,standard rat chow (for 8 days),sunitinib (7 mg/kg/d) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin potassium amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0002773,skin potassium level to skin water level ratio,,skin k/h2o,,80,mmol/l,1.1,2.9103,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99155,standard rat chow (for 8 days),vehicle control condition (0.5 ml) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin mineral amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0002772,skin potassium level plus skin sodium level to skin water level ratio,,skin na+k/h2o,,0.171,,0.004,0.0113,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99146,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),sunitinib (7 mg/kg/d) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin mineral amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0002772,skin potassium level plus skin sodium level to skin water level ratio,,skin na+k/h2o,,0.176,,0.008,0.0212,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99145,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),vehicle control condition (0.5 ml) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin mineral amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0002772,skin potassium level plus skin sodium level to skin water level ratio,,skin na+k/h2o,,0.167,,0.003,0.0085,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99144,standard rat chow (for 8 days),sunitinib (7 mg/kg/d) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin mineral amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0002772,skin potassium level plus skin sodium level to skin water level ratio,,skin na+k/h2o,,0.17,,0.001,0.0026,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99143,standard rat chow (for 8 days),vehicle control condition (0.5 ml) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood cystatin C amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0002778,plasma cystatin C level,,,,3.9,mg/l,0.3,0.8485,MMO:0000352,automated plasma protein analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99178,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),sunitinib (7 mg/kg/d) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood cystatin C amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0002778,plasma cystatin C level,,,,3.5,mg/l,0.2,0.5292,MMO:0000352,automated plasma protein analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99177,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),vehicle control condition (0.5 ml) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood cystatin C amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0002778,plasma cystatin C level,,plasma cystatin c,,4.7,mg/l,0.3,0.8485,MMO:0000352,automated plasma protein analysis,,0.0,,,,,standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99176,standard rat chow (for 8 days),sunitinib (7 mg/kg/d) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",blood cystatin C amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0002778,plasma cystatin C level,,,,4,mg/l,0.6,1.5875,MMO:0000352,automated plasma protein analysis,,0.0,,,,,standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99175,standard rat chow (for 8 days),vehicle control condition (0.5 ml) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",urine sodium amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0000760,urine sodium excretion rate,,,,34.3,mEq/d,1.8,5.0912,MMO:0000434,urine sodium analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99186,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),sunitinib (7 mg/kg/d) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",urine sodium amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0000760,urine sodium excretion rate,,,,41.9,mEq/d,5.2,13.7579,MMO:0000434,urine sodium analysis,,0.0,,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99185,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),vehicle control condition (0.5 ml) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",urine sodium amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0000760,urine sodium excretion rate,,,,1.1,mEq/d,0.1,0.2828,MMO:0000434,urine sodium analysis,,0.0,,,,,standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99184,standard rat chow (for 8 days),sunitinib (7 mg/kg/d) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",urine sodium amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0000760,urine sodium excretion rate,,mmol/d,,1,mEq/d,0.2,0.5292,MMO:0000434,urine sodium analysis,,0.0,,,,,standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99183,standard rat chow (for 8 days),vehicle control condition (0.5 ml) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin water amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0002771,skin water level to skin dry weight ratio,,skin h2o ml/g,,1.522,ml/g,0.004,0.0113,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99142,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),sunitinib (7 mg/kg/d) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin water amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0002771,skin water level to skin dry weight ratio,,skin h2o ml/g,,1.432,ml/g,0.032,0.0847,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99141,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),vehicle control condition (0.5 ml) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin water amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0002771,skin water level to skin dry weight ratio,,skin h2o ml/g,,1.208,ml/g,0.019,0.0537,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99140,standard rat chow (for 8 days),sunitinib (7 mg/kg/d) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin water amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0002771,skin water level to skin dry weight ratio,,skin h2o ml/g,,1.223,ml/g,0.032,0.0847,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,standard rat chow (for 8 days) then sunitinib (0.5 ml) (for 8 days),99139,standard rat chow (for 8 days),sunitinib (0.5 ml) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin sodium amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0002769,skin sodium level to skin dry weight ratio,,mmol/g,,0.164,REQUEST NEW VALUE,0.009,0.0255,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99134,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),sunitinib (7 mg/kg/d) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin sodium amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0002769,skin sodium level to skin dry weight ratio,,mmol/g,,0.144,REQUEST NEW VALUE,0.005,0.0132,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99133,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),vehicle control condition (0.5 ml) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin sodium amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0002769,skin sodium level to skin dry weight ratio,,mmol/g,,0.112,REQUEST NEW VALUE,0.002,0.0057,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99132,standard rat chow (for 8 days),sunitinib (7 mg/kg/d) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin sodium amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0002769,skin sodium level to skin dry weight ratio,,mmol/g,,0.11,REQUEST NEW VALUE,0.003,0.0079,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99131,standard rat chow (for 8 days),vehicle control condition (0.5 ml) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin chloride amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0002770,skin chloride level to skin dry weight ratio,,skin cl mmol/g,,0.073,mmol/g,0.007,0.0198,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99138,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),sunitinib (7 mg/kg/d) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin chloride amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0002770,skin chloride level to skin dry weight ratio,,skin cl mmol/g,,0.068,mmol/g,0.006,0.0159,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99137,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),vehicle control condition (0.5 ml) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin chloride amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0002770,skin chloride level to skin dry weight ratio,,skin cl mmol/g,,0.052,mmol/g,0.003,0.0085,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99136,standard rat chow (for 8 days),sunitinib (7 mg/kg/d) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin chloride amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0002770,skin chloride level to skin dry weight ratio,,skin cl mmol/g,,0.051,mmol/g,0.003,0.0079,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99135,standard rat chow (for 8 days),vehicle control condition (0.5 ml) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin chloride amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0002775,skin chloride level to skin water level ratio,,skin cl/h2o,,50,mmol/l,4.4,12.4451,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99154,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),sunitinib (7 mg/kg/d) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin chloride amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0002775,skin chloride level to skin water level ratio,,skin cl/h2o,,48,mmol/l,4.8,12.6996,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99153,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),vehicle control condition (0.5 ml) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin chloride amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0002775,skin chloride level to skin water level ratio,,skin cl/h2o,,43,mmol/l,1.5,4.2426,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99152,standard rat chow (for 8 days),sunitinib (7 mg/kg/d) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin chloride amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0002775,skin chloride level to skin water level ratio,,skin cl/h2o,,42,mmol/l,2.4,6.3498,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99151,standard rat chow (for 8 days),vehicle control condition (0.5 ml) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin chloride amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0002775,skin chloride level to skin water level ratio,,skin na/h2o,,108,mmol/l,4.4,12.4451,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99150,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),sunitinib (7 mg/kg/d) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin chloride amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0002775,skin chloride level to skin water level ratio,,skin na/h2o,,101,mmol/l,3.9,10.3184,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99149,controlled sodium content diet (8 %) (for 8 days),0.9% sodium chloride solution (0.9 %) (for 8 days),vehicle control condition (0.5 ml) (for 8 days) 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin chloride amount,,RS:0000916,WKY/NHsd,male,0 days,8,,CMO:0002775,skin chloride level to skin water level ratio,,skin na/h2o,,92,mmol/l,1.5,4.2426,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days),99148,standard rat chow (for 8 days),sunitinib (7 mg/kg/d) (for 8 days), 2238,"Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.",skin chloride amount,,RS:0000916,WKY/NHsd,male,0 days,7,,CMO:0002775,skin chloride level to skin water level ratio,,skin na/h2o,,90,mmol/l,0.8,2.1166,MMO:0000584,ex vivo analysis of atomic composition following dry ashing,,0.0,ashed skin,,,,standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days),99147,standard rat chow (for 8 days),vehicle control condition (0.5 ml) (for 8 days),